Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Hemorrhage 2Sexual Infantilism 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Myoma 1Myofibroma 1Leiomyoma 1Diabetes Insipidus 1Craniopharyngioma 1Blood Loss, Surgical 1

Interventions

Surgical Procedures, Operative 3Exenatide 3tocilizumab 2Surveys and Questionnaires 2Radiotherapy 2Proton Therapy 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Donepezil 2trametinib 1tozuleristide 1tovorafenib 1temsirolimus 1gallium Ga 68 dotatate 1dabrafenib 1cobimetinib 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1anlotinib 1Vemurafenib 1Tumor Burden 1Transurethral Resection of Bladder 1Thalidomide 1Temozolomide 1Radiotherapy, Image-Guided 1Radiation 1Qsymia 1Prednisone 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Craniopharyngioma × Oxytocin × Clear all
NCT02849743 2022-10-05

Intranasal Oxytocin in Hypothalamic Obesity

Children's Hospital of Philadelphia

Phase 2 Completed
18 enrolled 18 charts
CNS

Craniopharyngioma, Sexual Infantilism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡